BELGRADE – The Medicines and Medical Devices Agency of Serbia (ALIMS) signed a Memorandum of Understanding (MoU) and cooperation with the Federal Service for Supervision of Healthcare of the Russian Federation (Roszdravnadzor) on Friday.
“This agreement relates to cooperation between the two regulatory bodies in different areas. These include laboratory quality control of medicines and medical supplies, drug safety monitoring and responding to cases of contraindication. We will also jointly fight against drug falsification,” ALIMS Director Sasa Jacovic said after signing the memorandum.
Roszdravnadzor has only signed such MoUs with regulatory authorities for medicines and medical devices of the world’s biggest states – the United States, India and China.
Mikhail Murashko, Acting Head of Roszdravnadzor, pointed out that the preparation of the memorandum took a whole year and the signing was a major step in improving cooperation between the two agencies.
The Russian delegation visited today the ALIMS’ National Control Laboratory, which is one of the best rated and most highly respected laboratories within the Council of Europe member states’ network of control laboratories.
All this has been confirmed many times, a few times in 2014 alone, through assessments by relevant international bodies and organizations – the European Medicines Agency (EMA, based in London), the European Directorate for the Quality of Medicines and Health Care (EDQM, a Council of Europe directorate based in Strasbourg), and the World Health Organization (WHO).
Serbian pharmaceutical companies’ sell up to USD 100 million worth of medicies on the Russian Market.
“This agreement relates to cooperation between the two regulatory bodies in different areas. These include laboratory quality control of medicines and medical supplies, drug safety monitoring and responding to cases of contraindication. We will also jointly fight against drug falsification,” ALIMS Director Sasa Jacovic said after signing the memorandum.
Roszdravnadzor has only signed such MoUs with regulatory authorities for medicines and medical devices of the world’s biggest states – the United States, India and China.
Mikhail Murashko, Acting Head of Roszdravnadzor, pointed out that the preparation of the memorandum took a whole year and the signing was a major step in improving cooperation between the two agencies.
The Russian delegation visited today the ALIMS’ National Control Laboratory, which is one of the best rated and most highly respected laboratories within the Council of Europe member states’ network of control laboratories.
All this has been confirmed many times, a few times in 2014 alone, through assessments by relevant international bodies and organizations – the European Medicines Agency (EMA, based in London), the European Directorate for the Quality of Medicines and Health Care (EDQM, a Council of Europe directorate based in Strasbourg), and the World Health Organization (WHO).
Serbian pharmaceutical companies’ sell up to USD 100 million worth of medicies on the Russian Market.
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου